IGT Signs Agreement to Deploy 720 Sierra27 Video Lottery Terminals Across Saskatchewan
Selected through WCLC's competitive VLT procurement process for a second consecutive year
"WCLC selected IGT through a competitive procurement process, and these additional Sierra27 VLTs will support our venue network with hardware and content designed for the Canadian market," said
"As the leading VLT supplier in
IGT's versatile Sierra27 VLT delivers comfort and serviceability and features two high-definition 27-inch screens, a 13.3-inch dynamic player panel with dual bash buttons, and a wireless inductive charger. The Sierra27 VLT is backed by a large library of high-performing content and games designed specifically for players in
For more information visit IGT.com or follow us on LinkedIn and YouTube.
About IGT
IGT is a leading global provider of gaming, digital and financial technology solutions, formed through the combination of International Game Technology PLC's Gaming & Digital Business and Everi Holdings Inc. IGT's offering spans gaming machines, game content and systems, iGaming, sports betting, cash access, loyalty and player engagement solutions, enabling it to deliver integrated, customer-centric experiences across land-based and digital environments. Organized into Gaming, Digital and FinTech business units, IGT drives innovation, efficiency and value for casino, digital and hospitality operators worldwide. The company is headquartered in Las Vegas.
Contact:
Phil O'Shaughnessy, Global Communications, toll free in U.S./Canada +1 (844) IGT-7452; outside U.S./Canada +1 (775) 448-0257
© 2026 IGT
The trademarks and/or service marks used herein are either trademarks or registered trademarks of IGT, its affiliates or its licensors.
View original content to download multimedia:https://www.prnewswire.com/news-releases/igt-signs-agreement-to-deploy-720-sierra27-video-lottery-terminals-across-saskatchewan-302829721.html
SOURCE IGT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flagship Pioneering Awarded First-Of-Its-Kind Contract by Department of War to Advance Next-Generation Medical Countermeasure Technologies Against Evolving Biological Threats
- Target Corporation Declares Regular Quarterly Dividend
- Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share